CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
GORE® VIABAHN® Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02462876
NCT02462876N/ACompleted
CompareCT.gov

Post-market Study: Evaluation of the GORE® VIABAHN® Endoprosthesis for the Treatment of Popliteal Artery Aneurysm

W.L.Gore & Associates·observational·Posted Jun 4, 2015·Updated Mar 28, 2022

In Brief

An observational study evaluating GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study will assess the long term safety and performance of the GORE® VIABAHN® Endoprosthesis for the treatment of patients with Popliteal Artery Aneurysms.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPopliteal Artery Aneurysm
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 4, 2015
Enrollment StartOct 1, 2015
Primary CompletionJul 1, 2018
Study CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.1 years ago

Interventions

GORE® VIABAHN® Endoprosthesisdevice

Treatment of Popliteal Artery Aneurysm with the GORE® VIABAHN® Endoprosthesis.